OTC
Partner for Managing OTC Packaging, Labeling, and Fluctuating Market Demand
CPL applies the same rigorous GMP, microbiological control, and technical depth to OTC semi-solid and liquid products as we do to prescription brand and generic drugs. Our teams routinely develop and manufacture monograph-compliant and NDA-pathway products, including cough syrups, topical pain relievers, antifungal creams, skin barrier formulations, antiseptics, nasal sprays, and more. We are key partners in helping you navigate labeling and packaging requirements and in leveraging our agile operational capabilities to respond quickly to changes in market conditions.
Packaging, Labeling & Lifecycle Support for OTC Brands
CPL understands that OTC success depends on more than formulation. We support tamper-resistant packaging, consumer-ready labeling, proactive regulatory oversight, and agile supply strategies to protect patients, safeguard brands, and keep high-volume OTC portfolios on shelves worldwide.
Tamper-Resistant Packaging
Because OTC medicines are sold directly to consumers and displayed in open retail environments, they face a higher risk of accidental or deliberate interference than prescription products dispensed by a pharmacist. Tamper-evident, tamper-resistant packaging is essential to protect patients, maintain brand trust, and meet regulatory expectations. Clear, robust tamper features and on-pack statements help consumers quickly identify compromised products and support safe self-selection and use. CPL has more than 35 years of experience helping clients navigate these demands.
Discover More Packaging Capabilities
Package Design & Labeling
Consumers are self-diagnosing and self-selecting OTC drug products, meaning package labeling and design play a significant role in communicating with patients and presenting a visually appealing product on store shelves. Clear drug facts-style panels, standardized headings, and plain-language warnings help consumers understand active ingredients, indications, contraindications, and dosing. Global brands must also reconcile US, Canadian, and EU formatting, language, and content rules while preserving brand consistency and shelf impact. CPL is adept at managing a range of packaging and labeling for different runs.
Explore Packaging & Labeling Capabilities
Regulatory & Product Lifecycle Management
OTC brands reach the market by leveraging a monograph that establishes the conditions under which drugs are “generally recognized as safe and effective” (GRASE) and not misbranded, or an NDA pathway. However, the requirements of leading global regulators evolve, requiring regulatory change tracking, label, packaging, and claim alterations, and the management of reformulations and line extensions without disrupting supply. Because OTC portfolios often include many SKUs across numerous global markets, sponsors need robust change control and packaging/labeling management to maintain compliance, avoid recalls, and support rapid, market-driven updates. CPL’s packaging, quality, and regulatory teams offer expert support for managing these dynamic factors.
Agile Supply to Match OTC Demand
CPL’s agile operations are built to handle the volatility of consumer brands, from seasonal cold-and-flu surges to promotion-driven demand spikes. Flexible scheduling, right-sized batch strategies, and multi-format packaging lines help us rapidly scale OTC semi-solid and non-sterile liquid production without compromising quality. Robust forecasting, safety-stock approaches, and close coordination with your supply and marketing teams support reliable on-shelf availability, even when demand curves shift quickly.
CPL Experience Spotlight
CPL Helped Long-Time Product Keep Product on Store Shelves
Dedicated to Excellence
from Molecule to Commercialization
CPL supports programs from early-phase through commercial launch, combining preformulation insight, robust semi-solid and non-sterile liquid development, scalable process design, and clinical and commercial manufacturing.
Pharmaceutical Development Services
Pharmaceutical Development Services
Comprehensive expertise that turns molecules into scalable, compliant, market‑ready semi-solid and non-sterile therapies.
Analytical & Product Testing
Analytical & Product Testing
Robust analytics power confident development and manufacture of topical and non-sterile liquid products.
Clinical & Commercial Manufacturing
Clinical & Commercial Manufacturing
More than three decades of GMP manufacturing experience from clinical supply through commercialization.
Packaging, Labeling & Serialization
Packaging, Labeling & Serialization
Integrated packaging, serialization, and aggregation ensure compliant, continuous commercial supply.
Semi-Solid & Non-Sterile Liquid Expertise
Semi-Solid & Non-Sterile Liquid Expertise
Pure-play CDMO for semi-solids and non-sterile liquids, with advanced micro encapsulation capabilities.
Unique Product Handling Experience
Unique Product Handling Experience
Infrastructure and expertise to manage complex, higher-risk semi-solid and non-sterile liquid products.
FAQs
-
CPL develops and manufactures a broad range of OTC semi-solid and non-sterile liquid products, from cough syrups and oral solutions to topical pain relievers, anti-inflammatories, antifungal creams, skin barrier and moisturizing formulations, antiseptic and wound care products, nasal sprays, and more. We support both monograph-compliant and NDA-pathway OTC products, offering formulation, scale-up, commercial manufacturing, and packaging services that help sponsors maintain quality, compliance, and dependable supply across complex, multi-SKU portfolios.
-
From a GMP and microbiological standpoint, OTC and prescription products are held to the same high standards. The fundamental differences lie in greater demands for labeling, tamper-evident packaging, and lifecycle management. OTC products must enable safe self-selection and self-use, meet specific Drug Facts or equivalent labeling requirements, and withstand open retail environments. CPL’s teams understand these nuances and design manufacturing, packaging, and quality systems that support global OTC regulations while preserving brand impact and on-shelf reliability.
-
CPL is experienced in managing OTC packaging and labeling that must comply with U.S. Drug Facts requirements, Canadian Plain Language Labelling and Drug Facts Tables, EU readability and multilingual expectations, as well as those of other global markets. We coordinate closely with your regulatory and artwork teams to implement country-specific claims, warnings, and formats while maintaining brand consistency. Our packaging lines accommodate multiple formats and pack sizes, helping sponsors efficiently manage updates, line extensions, and market-specific variants without sacrificing speed or quality.
-
Non-sterile OTC liquids and semi-solids are often multi-dose, repeatedly opened, and stored in variable home environments, which makes microbiological quality and preservative performance critical. CPL applies a risk-based approach that considers formulation attributes, preservative systems, container-closure design, hold times, and in-process controls. We design and validate robust cleaning, environmental, and microbial monitoring programs and align product specifications with pharmacopeial expectations. The result is OTC products that meet stringent quality standards and perform reliably over their intended shelf life.
Commitment.
Partnership. Legacy.
Leverage CPL’s 35 years of expertise in non-sterile liquids and semi-solids to ensure your program's success. We’ll support your product from molecule to market, or step in at any stage of its product lifecycle.
